SMTL ID : 4wnm.1

SYK catalytic domain in complex with a potent triazolopyridine inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x 3RT: N~3~-(tetrahydro-2H-pyran-4-yl)-N~6~-[5-(tetrahydro-2H-pyran-4-ylmethyl)[1,2,4]triazolo[1,5-a]pyridin-2-yl]-1H-indazole-3,6-diamine(Non-covalent)

3RT.1: 18 residues within 4Å: Chain A: L.35, G.36, V.43, A.58, M.106, E.107, M.108, A.109, E.110, G.112, P.113, K.116, Q.120, R.156, N.157, L.159, S.169, D.170 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.35, A:L.35, A:V.43, A:A.58, A:L.159 Hydrogen bonds: A:A.109, A:A.109, A:D.170

1 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 7 residues within 4Å: Chain A: R.151, K.175, Y.184, A.186, T.188, G.190, W.192 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:G.190 Salt bridges: A:R.151, A:K.175

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ferguson, G.D. et al., A Novel Triazolopyridine-Based Spleen Tyrosine Kinase Inhibitor That Arrests Joint Inflammation. Plos One (2016)

Release Date

2016-01-20

Peptides

Tyrosine-protein kinase SYK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase SYK

Related Entries With Identical Sequence